Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin versus tranexamic acid for reduction of blood loss during myomectomy
PACTR201908793583382Completed
- Sponsor
- Faculty of Medicine, Suez Canal University
- Start
- May 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Trial of carbetocin and tranexamic acid in Fibromyoma (LM) (2 arms), sponsored by Faculty of Medicine, Suez Canal University. Primary endpoints: Operative blood loss and Need for blood transfusion. Started May 2016; status: completed.
02
Drugs
carbetocintranexamic acid
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR201908793583382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201908793583382.